Wes Burk, cofounder and vice president of Emerald Scientific, discusses this year's Emerald Conference, some of Emerald’s other initiatives in cannabis science, and their plans going into 2020
The Emerald Conference will be taking place in a few short weeks (February 26–29) in beautiful San Diego, California. We recently spoke with Wes Burk, cofounder and vice president of Emerald Scientific, about the conference, some of Emerald’s other initiatives in cannabis science, and their plans going into 2020.
What’s new at this year’s Emerald Conference? What do you look forward to the most?
Wes Burk: The most exciting thing about this year’s Emerald Conference is the content. We have a 31-member scientific committee that has helped curate the content and quality of presentations, so this year promises to be even more cutting edge than previous years. Additionally, we have added a “Quality Summit” on Saturday which will focus on current good manufacturing practices (cGMP), standardization, and features a special Nomenclature Workshop. These are pressing topics that this industry is currently feverishly addressing.
It was recently announced that The Emerald Conference was purchased by Marijuana Business Daily (MJBiz). How will that acquisition change future editions of The Emerald Conference? Do you hope to expand your reach of bringing cannabis science to a broader audience?
Burk: This acquisition represents an evolution in a long standing relationship between MJBiz Daily and Emerald Scientific. The partnership will continue and allows each organization to leverage its strengths. MJBiz will bring logistics, support, and exposure for the conference to an unprecedented level allowing Emerald Scientific to continue to collaborate on the curation of scientific content. We will certainly reach a broader audience such as bio tech and life sciences while continuing to set the standard for content. This is a very positive partnership for all of cannabis science!
What prompted you to create your webinar series Extraction Efficiency? What feedback or engagement have you received?
Burk: The Emerald Extraction Efficiency series was created to introduce newer extraction professionals to the complexities of supercritical extraction and help inspire a more sophisticated approach to running extraction labs. There are so many variables that need to be understood and managed to tune extractions and thereby maximize return on investment (ROI) for those operations. The Emerald Extraction Efficiency series does a great job of discussing best practices around which to build processes.
Can you talk about your work with the development of the Emerald Test? What have you learned through executing this test?
Burk: The Emerald Test was created to help quality assurance labs meet oversight and accreditation requirements. It has evolved into an industry benchmark, showing trends and areas of challenge for analysis of what is a very complex plant with ever evolving matrixes that must be dealt with.
What advice would you give to labs that have not yet enrolled in the Emerald Test?
Burk: Not only does the Emerald Test satisfy regulatory requirements and accreditation requirements in most cases, it also gives a lab the ability to see how they perform compared to other labs around the world due to the Inter-Laboratory Comparison component of the test. If a lab performs well, they also receive the Emerald Badge which can be used to show the public they are proficient in these disciplines and many labs are using their badges aggressively in their marketing.
What other standards or accreditations do you want to see established in the cannabis industry?
Burk: When it comes to standards, what we would most like to see is the creation and validation of standard methods for across the major testing categories: potency, residual solvents, microbial, heavy metals, and pesticide analysis. This would be a tremendous step towards ensuring consumers can better trust the labels and make sound purchasing decisions normalizing outcomes to expectations.
Through your company Emerald Scientific, the Emerald Conference, your webinar series on extractions, your help developing the Emerald Test, and your advocacy, what do you most want to accomplish for the cannabis industry?
Burk: One of the core values that Emerald Scientific is proud to promote is quality science. Only through rigorous science can we build an industry on predictable, reliable outcomes for patients and consumers and only then can we expect our industry to continue to thrive.
You have developed so many tools and resources for the industry, what’s next for you?
Burk: 2020 promises to be a very exciting year for Emerald Scientific! We have just launched our Canadian subsidiary and we look forward to the new opportunities and relationships we are forging there. We are also proud of our newly announced partnership with PerkinElmer and now, with capital instrumentation, are thrilled to bring a full suite of solutions to the cannabis industry.
Inside the University of Maryland School of Pharmacy’s Graduate Program in Medical Cannabis
September 16th 2024Leah Sera, PharmD, MA, the co-program director for the University of Maryland School of Pharmacy’s Graduate Studies in Medical Cannabis program sat down with Cannabis Science and Technology to discuss higher education in medical cannabis.
Studying the Evolution of Cannabis Education: Insights from Stockton University’s Course Instructors
September 13th 2024A leader in cannabis education in New Jersey, Stockton University offers a wide variety of courses to prepare its students to not only succeed in an ever-growing industry, but to also understand its complex history and shape its evolving future. Started six years ago, its Cannabis Studies Program continues its commitment to providing innovative and practical instruction to its students. Two influential figures in this space are Robert Mejia, Teaching Specialist in the Cannabis Studies Program, and Angela Speakman, Instructor in the Cannabis Studies Program. Here, they highlight the program’s practical approach to cannabis education, celebrate the success stories of graduates, discuss the National Cannabis Curriculum Convening, and address challenges in cannabis education and its role in the future.
Medical Cannabis Campaigning with Americans for Safe Access
September 4th 2024As discussions about the federal scheduling of cannabis continue, efforts by medical cannabis advocates are intensifying. One such advocate is Americans for Safe Access (ASA), a nonprofit organization founded by patients for patients. Since 2002, ASA has been championing the rights of medical cannabis patients and has recently launched new campaigns and strategies to refocus attention on patient needs. In this interview, Steph Sherer, founder and president of ASA, reflects on past successes in medical cannabis advocacy, shares her perspective on recent cannabis and hemp policymaking, and outlines the next steps for advancing a unified medical cannabis message on Capitol Hill—a message that could bring about the changes patients have long awaited.
Insights on Cannabis Testing Challenges and Industry Standards: An Interview with Douglas Duncan
August 9th 2024In light of recent headlines concerning cannabis laboratories throughout the country, Cannabis Science and Technology reached out to Douglas Duncan, Laboratory Director of Kairos Labs in Detroit, MI and member of our Editorial Advisory Board for more information. In this interview, Duncan shares his perspectives on lab shopping, major challenges in the industry today, and innovations in cannabis testing laboratories for the future. He also shares insights into consumer practices and the potential effects of a federal rescheduling of cannabis.
Patients on the Front Line: Nikki Lawley’s Insights on Medical Cannabis Today
June 25th 2024In the ongoing dialogue surrounding cannabis, the testimonials of medical cannabis patients stand as crucial reminders of its impacts and benefits in the industry. For a deep dive into this topic, Cannabis Science and Technology sat down with Nikki Lawley, founder of Nikki and the Plant, LLC, for her take on the challenges patients face today in the midst of discussions of industry developments such as the rescheduling of cannabis. A traumatic brain injury survivor, Lawley now actively supports medical cannabis access and engages diverse audiences through her journey as a pediatric nurse-turned-patient-and-advocate. Here, she explains the importance of educating people about cannabis, the need for patient perspective in cannabis policy decisions, and the benefits of empathetic approaches to medical cannabis use.
Foundations for the Future: The University of Rhode Island’s Cannabis Education Program
March 5th 2024The continued expansion of the cannabis industry, particularly in the new recreational market in Rhode Island, is simultaneously increasing the opportunities for professions as well. One advantage here is education; formal training from experts provides an edge for those looking to lead and innovate in their field. In response to this need, the University of Rhode Island (URI) offers an Undergraduate Certificate in Cannabis Studies, a minor in cannabis studies, an upcoming Graduate Certificate in Cannabis Sciences, and more in order to evolve the way students learn and are prepared for the wide-ranging opportunities in the cannabis industry. In this interview, Program Director Stephanie Forschner-Dancause, PhD, shares insights into the curriculum of URI’s cannabis courses as they prepare students to ensure the industry's future is credible and grounded in evidence-based practices.